Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial-Reference-Cited by-同舟云学术

Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial

Published:2018-10-21 Issue:11 Volume:44 Page:1787-1796
ISSN:0342-4642
Container-title:Intensive Care Medicine
language:en
Short-container-title:Intensive Care Med

Author:

François Bruno^ORCID, ,Mercier Emmanuelle,Gonzalez Céline,Asehnoune Karim,Nseir Saad,Fiancette Maud,Desachy Arnaud,Plantefève Gaëtan,Meziani Ferhat,de Lame Paul-André,Laterre Pierre-François

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

http://link.springer.com/article/10.1007/s00134-018-5229-2/fulltext.html

Reference25 articles.

1. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O’Grady NP, Bartlett JG, Carratalà J, El Solh AA, Ewig S, Fey PD, File TM Jr, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63:e61–e111. https://doi.org/10.1093/cid/ciw353

2. Gastmeier P, Sohr D, Geffers C et al (2009) Early- and late-onset pneumonia: is this still a useful classification? Antimicrob Agents Chemother 53:2714–2718. https://doi.org/10.1128/AAC.01070-08

3. Diekema DJ, Pfaller MA, Schmitz FJ et al (2001) Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 32(Suppl 2):S114–S132. https://doi.org/10.1086/320184

4. Chambers HF (2001) The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7:178–182. https://doi.org/10.3201/eid0702.700178

5. Athanassa Z, Siempos II, Falagas ME (2008) Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review. Eur Respir J 31:625–632. https://doi.org/10.1183/09031936.00081007

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections;Clinical Microbiology Reviews;2024-09-12

2. Forssman and the staphylococcal hemolysins;APMIS;2024-08-27

3. Characterization of mAbs against Klebsiella pneumoniae type 3 fimbriae isolated in a target-independent phage display campaign;Microbiology Spectrum;2024-08-06

4. Treatment of MRSA Infection: Where are We?;Current Medicinal Chemistry;2024-08

5. Effects of nursing team communication and collaboration on treatment outcomes in intensive care unit patients with severe pneumonia;World Journal of Clinical Cases;2024-07-16